Seres Therapeutics, Inc. 4
4 · Seres Therapeutics, Inc. · Filed Feb 3, 2016
Insider Transaction Report
Form 4
Trucksis Michele
Chief Medical Officer and EVP
Transactions
- Award
Stock Option (Right to Buy)
2016-02-01+62,500→ 62,500 totalExercise: $26.20Exp: 2026-01-31→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares subject to the option on February 1, 2017, and as to an additional 6.25% of the total number of shares subject to the option upon the completion of each three consecutive months of service thereafter.